Michael Jendrusch; Alessio Ling Jie Yang; Elisabetta Cacace; Jacob Bobonis; Carlos Geert Pieter Voogdt; Sarah Kaspar; Kristian Schweimer; Cecilia Perez-Borrajero; Karine Lapouge; Jacob Scheurich; Kim Remans; Janosch Hennig; Athanasios Typas; Jan O. Korbel; S. Kashif Sadiq · 2025 · Molecular Systems Biology
Paper
De novo protein design is of fundamental interest to synthetic biology, with a plethora of computational methods of various degrees of generality developed in recent years. Here, we introduce AlphaDesign, a hallucination-based computational framework for de novo protein design developed with maximum generality and usability in mind, which combines AlphaFold with autoregressive diffusion models to enable rapid generation and computational validation of proteins with controllable interactions, conformations and oligomeric state without the requirement for class-dependent model re-training or fine-tuning. We apply our framework to design and systematically validate in vivo active inhibitors of a family of bacterial phage defense systems with toxic effectors called retrons, paving the way towards efficient, rational design of novel proteins as biologics.
Analysis
AlphaDesign is a novel, hallucination-based computational framework for de novo protein design that integrates AlphaFold with autoregressive diffusion models for rapid generation and validation of proteins with controllable properties.
Discovery
Hoda M. Hammad; Anna M. Duraj‐Thatte
Jakob Agamia; Martin Zacharias
Yap V; Xu P; Mak FS; Foo K; Kang C; Anbazhagan P; Xu W
Hun Hee Cho; Tae Hyung Kim; Seung Gyu Hwang; Hongchul Shin
Bruce J. Wittmann; Tessa Alexanian; Craig Bartling; Jacob Beal; Adam Clore; James Diggans; Kevin Flyangolts; Bryan T. Gemler; Tom Mitchell; Steven T. Murphy; Nicole E. Wheeler; Eric Horvitz
Guohao Zhang; Chuanyang Liu; Jiajie Lu; Shaowei Zhang; Lingyun Zhu
Source record